Type 2 diabetes and HbA1c goal: time for individualised therapy

被引:0
|
作者
Jabbour, S. [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Div Endocrinol Diabet & Metab Disorders, Philadelphia, PA 19107 USA
关键词
GLUCOSE CONTROL;
D O I
10.1111/j.1742-1241.2009.02158.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1409 / 1409
页数:1
相关论文
共 50 条
  • [1] Impact of type 2 diabetes patients' knowledge of their individualised HbA1c goal on glycaemic control
    Boggs, R.
    Lautsch, D.
    Milligan, G.
    Higgins, V.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S309 - S309
  • [2] The management of type 2 diabetes: Is HbA1c the only goal?
    Bauduceau, B.
    Bordier, L.
    Dupuy, O.
    Garcia, C.
    Mayaudon, H.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (10): : 560 - 563
  • [3] THE IMPACT OF BASELINE HBA1C AND HBA1C TRAJECTORIES ON TIME TO THERAPY ESCALATION IN TYPE 2 DIABETES MELLITUS
    McEwan, P.
    Foos, V
    Larnotte, M.
    VALUE IN HEALTH, 2015, 18 (07) : A698 - A698
  • [4] Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes
    Giugliano, D.
    Esposito, K.
    DIABETIC MEDICINE, 2011, 28 (02) : 247 - 247
  • [5] Role of Initial Combination Therapy on Goal Attainment among Patients with Type 2 Diabetes with High HbA1c
    Klok, Rogier M.
    Gulati, Tania
    Rajpathak, Swapnil
    Pal, Sampriti
    Yang, Lingfeng
    Bandyopadhyay, Ashmita
    Khunti, Kamlesh
    DIABETES, 2019, 68
  • [6] Individualised HbA1c targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study
    Khunti, K.
    Chen, H.
    Cid-Ruzafa, J.
    Fenici, P.
    Gomes, M. B.
    Hammar, N.
    Kennedy, K. F.
    Pocock, S.
    Shestakova, M. V.
    Shimomura, I.
    Surmont, F.
    Ji, L.
    DIABETOLOGIA, 2018, 61 : S175 - S175
  • [7] HbA1c as a shared treatment goal in type 2 diabetes? A secondary analysis of the DEBATE trial
    Sara Santos
    Michael Pentzek
    Attila Altiner
    Anne Daubmann
    Eva Drewelow
    Christian Helbig
    Christin Löffler
    Susanne Löscher
    Karl Wegscheider
    Heinz-Harald Abholz
    Stefan Wilm
    Anja Wollny
    BMC Primary Care, 24
  • [8] HbA1c as a shared treatment goal in type 2 diabetes? A secondary analysis of the DEBATE trial
    Santos, Sara
    Pentzek, Michael
    Altiner, Attila
    Daubmann, Anne
    Drewelow, Eva
    Helbig, Christian
    Loeffler, Christin
    Loescher, Susanne
    Wegscheider, Karl
    Abholz, Heinz-Harald
    Wilm, Stefan
    Wollny, Anja
    BMC PRIMARY CARE, 2023, 24 (01):
  • [9] Dispersion of serum 1,5 anhydroglucitol values in patients with type 2 diabetes at goal of HbA1c
    Chavez, Jaime E. Villena
    Sanchez, Elsa R. Neira
    Ferrara, Luciano F. Poletti
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 199
  • [10] Initiation of combination therapy in type 2 diabetes patients with high HbA1c at diagnosis
    Klok, R.
    Gulati, T.
    Rajpathak, S.
    Pal, S.
    Yang, L.
    Bandyopadhyay, A.
    Khunti, K.
    DIABETOLOGIA, 2019, 62 : S177 - S177